Delivery Order SPE2D020D0005-SPE2D324F093Y
- Not listed
- This federal contract award is for the delivery of ondansetron orally disintegrating tablets (4 mg, 30 count) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract has a ceiling value of $2,842.80 and a completion date of July 7, 2025. It is a firm fixed-price delivery order contract, indicating that Chartwell RX LLC will be responsible for the full delivery of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024. Chartwell RX LLC is the prime contractor for this award,...
- This federal contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of 30-count packages of 8 mg ondansetron orally disintegrating tablets. Awarded by the Defense Logistics Agency (DLA) Troop Support Medical, this $3,946.20 firm fixed price delivery order does not have a set-aside designation. It is part of a larger $7 million-plus single-award indefinite delivery vehicle (IDV) contract held by Chartwell with DLA Troop Support...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the delivery of 8 mg ondansetron oral disintegrating tablets in 30-count packages, with a firm fixed price of $2,959.65 and a completion date of March 12, 2024. Chartwell RX is an experienced federal contractor, holding multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans...
- This federal contract award to Chartwell RX LLC, a for-profit pharmaceutical company, is for the delivery of 4,564,154 units of ondansetron 8 mg orally disintegrating tablets in packages of 30. The $1,578.48 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Chartwell RX holds two major indefinite delivery vehicle (IDV) contracts enabling long-term pharmaceutical supply to federal agencies. This award is...
- This is a firm-fixed-price delivery order contract awarded to Chartwell RX LLC, a for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ondansetron orally disintegrating tablets (8 mg, 30-count) to federal government agencies. The contract has a ceiling value of $1,973.10 and a period of performance ending on July 7, 2025. Chartwell RX LLC is a registered System for Award Management (SAM) vendor and has a history of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,973.10, is for the delivery of 4,564,795,757 units of ondansetron ODT 8 mg tablets in 30-count packages. The contract has a firm fixed price pricing type and a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and has been awarded several other federal contracts, including...
- This contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of ondansetron orally disintegrating tablets in 30-count packages. The $2,369.00 firm fixed-price delivery order was issued on November 8, 2024, with a completion date of November 14, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at over $7 million with the Defense Logistics Agency (DLA) Troop Support Medical, which allows...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $1,302.95 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, an antiemetic medication, to support government healthcare services. The contract has an ultimate completion date of June 6, 2025. Chartwell RX LLC is an experienced federal contractor, holding multiple Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company located in Congers, New York. The award is for a delivery order to supply ondansetron orally disintegrating tablets, an antiemetic medication, to the government. The contract has a ceiling value of $1,184.50 and a completion date of May 1, 2025. Chartwell RX LLC is the prime contractor, and there is no mention of any subcontractors. The award...
- SPE2D020D0005Indefinite Delivery Contract
- SPE2D020D0005-SPE2D324F093YDelivery Order
This federal contract award is for the delivery of ondansetron 8 mg orally disintegrating tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, on July 3, 2024. The fixed-price delivery order contract has a ceiling value of $19,731.00 and is set to expire on July 9, 2024. Chartwell RX is the prime contractor for this award and has established itself as a reliable supplier of both branded and generic pharmaceuticals to the federal government. The company holds two significant Indefinite Delivery Vehicles (IDVs) that facilitate its ongoing work with federal agencies, including a Federal Supply Schedule contract with the Department of Veterans Affairs and a single-award IDC with the DLA Troop Support Medical. This contract award is not associated with a set-aside program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 7/3/24 |